Clinical trials: Algoneurodystrophy, active
Algoneurodystrophy
Thrombotic RIsk FActors in AL-goneurodystrophy
The primary objective of the study is to evaluate the prevalence of blood prothrombotic factors in CRPS patients and their role in predicting response to neridronic acid treatment.
- Trial name
- TRIF-AL (NCT07435207)
- Where
- Italy
- Volunteers
- 120 people
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
Algoneurodystrophy, Amputation
Analgesic Amputation for Algodystrophy: Feedback From a Case Series
What is the aim of the research? The study aims to describe the time interval between amputation for post-traumatic complex regional pain syndrome (CRPS) and functional prosthetic fitting of the amputated limb, within a series of…
- Trial name
- AMPUTALGO (NCT07364266)
- Testing
- describe the time interval between amputation for post-traumatic algodystrophy and functional prosthetic fitting of the amputated limb
- Where
- 2 sites in France
- Volunteers
- 20 people
- Sponsor
- University Hospital, Brest